摘要
目的对妇科盆腔炎患者应用康妇消炎栓联合盐酸莫西沙星进行治疗,分析其临床疗效。方法选取我院2015年3月至2016年3月收治的盆腔炎患者104例,按照随机数字表法分成两组。对照组52例给予盐酸莫西沙星治疗,观察组52例在对照组基础上联合康妇消炎栓进行治疗,对比两组患者的治疗总有效率、临床症状消失时间、不良反应发生率及复发率。结果观察组患者治疗总有效率显著高于对照组,差异具有统计学意义(P<0.05);观察组患者临床症状消失时间、不良反应发生率及复发率显著低于对照组,差异具有统计学意义(P<0.05)。结论应用康妇消炎栓联合盐酸莫西沙星治疗盆腔炎能够有效改善患者临床效果,并降低不良反应发生率,安全性相对较高,该治疗方案值得在临床中推广应用。
Objective To analyze the efficacy of Kangfu Xiaoyan suppository combined with moxifloxacin on pelvic inflammatory disease. Methods One hundred and four cases of patients with pelvic inflammatory disease admitted in our hospital from March 2015 to March 2016 were selected as study subjects and divided into two groups according to the random number method. Fifty-two cases in the control group were given moxifloxacin hydrochloride treatment, and 52 cases in the observation group received Kangfu Xiaoyan suppository on the basis of the control group. The total effective rate, clinical symptoms disappearance time, the incidence rate of adverse reactions and recurrence rate were compared in the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group, the difference between the two groups was statistically significant (P〈0.05); the clinical symptoms disappearance time, the incidence rate of adverse reactions and the recurrence rate in the observation group were significantly lower than those of the control group, the differences between the two groups were statistically significant (P〈0.05). Conclusion Kangfu Xiaoyan suppository combined with moxifloxacin hydrochloride applied in the treatment of pelvic inflammation can effectively improve the clinical effect and reduce the incidence rate of adverse reaction, which is safe and worthy of popularization in clinic.
出处
《临床医学研究与实践》
2017年第3期98-99,共2页
Clinical Research and Practice
关键词
盆腔炎
盐酸莫西沙星
康妇消炎栓
pelvic inflammatory disease
moxifloxacin hydrochloride
Kangfu Xiaoyan suppository